Syneos Health appoints Michael Brooks as Chief Development OfficerSyneos Health has appointed Michael Brooks as its new chief development officer. In this newly created role, Brooks Share XSyneos Health appoints Michael Brooks as Chief Development Officerhttps://pharmaphorum.com/news/syneos-health-appoints-michael-brooks-as-chief-development-officer/
Why pharma shouldn’t forget about sites in a post-COVID worldThe pandemic forced massive changes to oncology sites to ensure patient safety and research continuity – but we Share XWhy pharma shouldn’t forget about sites in a post-COVID worldhttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/why-pharma-shouldnt-forget-about-sites-in-a-post-covid-world/
Syneos adds to European team with key hiresSyneos Health Communications has made several senior hires to strengthen its Europe-based team. A portfolio of Syneos Health Share XSyneos adds to European team with key hireshttps://pharmaphorum.com/news/syneos-adds-to-european-team-with-key-hires/
Thriving in COVID-19 with flexible marketing strategiesPharma sales is set to change forever. To keep afloat in the current climate, teams need to embrace Share XThriving in COVID-19 with flexible marketing strategieshttps://deep-dive.pharmaphorum.com/magazine/digital-health-innovation-2020/thriving-in-covid-19-with-flexible-marketing-strategies/
Syneos Health bolsters healthcare communications leadershipSyneos Health has made a series of senior appointments to the leadership of its communications business under new Share XSyneos Health bolsters healthcare communications leadershiphttps://pharmaphorum.com/news/syneos-health-cassidy-tender-dorrian/
ASCO 2020: Scientific advances & what’s impacting doctors and patientsDespite going virtual due to the COVID-19 pandemic, Jennifer Harris, an immuno-oncology expert from Syneos Health told pharmaphorum’s Share XASCO 2020: Scientific advances & what’s impacting doctors and patientshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/asco-2020-scientific-advances-and-the-impact-on-doctors-and-patients/
Syneos Health invests in Microsoft/Indegene platformBiopharma services company Syneos Health has taken a minority stake in Indegene Omnipresence, a partnership between life sciences Share XSyneos Health invests in Microsoft/Indegene platformhttps://pharmaphorum.com/news/syneos-health-microsoft-indegene-life-sciences-platform/
Boosting trial recruitment through patient engagementImproving clinical trial recruitment has long been a priority for pharma, but despite having a plethora of new Share XBoosting trial recruitment through patient engagementhttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/boosting-trial-recruitment-through-patient-engagement-syneos/
15 pharma trends for 2020Real world evidence, patient centricity and new digital experiences are among the top 15 trends set to change Share X15 pharma trends for 2020https://pharmaphorum.com/views-analysis-digital/15-pharma-trends-for-2020/
